ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
93,200.01
1.33%
S&P 500
6,021.63
0.57%
Dow Jones
44,860.31
0.28%
US Dollar vs Yen
152.2585
-0.49%
Brent Oil
72.355
-0.13%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) ニュース

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TRIB
日付受信時刻ニュースソース見出しコード企業名
2024/11/1607 : 00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
2024/11/1603 : 22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/11/1523 : 00GlobeNewswire Inc.Trinity Biotech Announces Q3 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
2024/11/1507 : 26Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
2024/11/0802 : 33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/11/0722 : 19GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
2024/10/2602 : 24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/10/2602 : 23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/10/2521 : 45GlobeNewswire Inc.Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureNASDAQ:TRIBTrinity Biotech PLC
2024/10/2521 : 45GlobeNewswire Inc.Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformNASDAQ:TRIBTrinity Biotech PLC
2024/10/0723 : 35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/10/0721 : 15GlobeNewswire Inc.Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
2024/10/0300 : 22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/10/0104 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/2519 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/2505 : 05GlobeNewswire Inc.Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health MarketNASDAQ:TRIBTrinity Biotech PLC
2024/09/2321 : 11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/2106 : 14Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
2024/09/1919 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/1905 : 05GlobeNewswire Inc.Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerNASDAQ:TRIBTrinity Biotech PLC
2024/09/1023 : 35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/1005 : 05GlobeNewswire Inc.Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
2024/09/0602 : 26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/0523 : 52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/0500 : 59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/09/0322 : 55GlobeNewswire Inc.Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial OfficerNASDAQ:TRIBTrinity Biotech PLC
2024/08/2919 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/08/2906 : 11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
2024/08/2801 : 33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/08/2705 : 05GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 SalesNASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

最近閲覧した銘柄

CCOM
US100
US Tech 100
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
FX
USDEUR
US Dollar vs Euro
NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
FX
USDGBP
US Dollar vs Sterling
CCOM
US30
US 30
NASDAQ
MSFT
Microsoft
NYSE
NKE
Nike
COIN
AVAXUSD
Avalanche
NASDAQ
AMZN
Amazon.com
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有

BLACK FRIDAY

ADVFN

25周年を記念 1999-2024

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％

*3年間で¥ 153396、たったの¥ 61358